ALDMS Statistics

Total Valuation

Diagnostic Medical Systems has a market cap or net worth of EUR 13.57 million. The enterprise value is 31.22 million.

Market Cap	13.57M
Enterprise Value	31.22M

Important Dates

The next estimated earnings date is Friday, December 20, 2024.

Earnings Date	Dec 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Diagnostic Medical Systems has 18.10 million shares outstanding. The number of shares has increased by 15.88% in one year.

Current Share Class	n/a
Shares Outstanding	18.10M
Shares Change (YoY)	+15.88%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.25%
Owned by Institutions (%)	n/a
Float	14.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.29
PB Ratio	1.23
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.07
EV / Sales	0.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.93

Financial Position

The company has a current ratio of 1.29, with a Debt / Equity ratio of 1.49.

Current Ratio	1.29
Quick Ratio	0.59
Debt / Equity	1.49
Debt / EBITDA	n/a
Debt / FCF	-9.43
Interest Coverage	-7.49

Financial Efficiency

Return on equity (ROE) is -100.58% and return on invested capital (ROIC) is -5.73%.

Return on Equity (ROE)	-100.58%
Return on Assets (ROA)	-3.81%
Return on Capital (ROIC)	-5.73%
Revenue Per Employee	372,208
Profits Per Employee	-81,232
Employee Count	134
Asset Turnover	0.93
Inventory Turnover	2.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.48% in the last 52 weeks. The beta is 1.03, so Diagnostic Medical Systems's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-26.48%
50-Day Moving Average	0.87
200-Day Moving Average	0.99
Relative Strength Index (RSI)	42.72
Average Volume (20 Days)	6,003

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diagnostic Medical Systems had revenue of EUR 46.53 million and -10.15 million in losses. Loss per share was -0.57.

Revenue	46.53M
Gross Profit	16.96M
Operating Income	-3.06M
Pretax Income	-15.09M
Net Income	-10.15M
EBITDA	-1.59M
EBIT	-3.06M
Loss Per Share	-0.57

Full Income Statement

Balance Sheet

The company has 2.14 million in cash and 18.49 million in debt, giving a net cash position of -16.34 million or -0.90 per share.

Cash & Cash Equivalents	2.14M
Total Debt	18.49M
Net Cash	-16.34M
Net Cash Per Share	-0.90
Equity (Book Value)	12.37M
Book Value Per Share	0.61
Working Capital	6.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.32 million and capital expenditures -3.28 million, giving a free cash flow of -1.96 million.

Operating Cash Flow	1.32M
Capital Expenditures	-3.28M
Free Cash Flow	-1.96M
FCF Per Share	-0.11

Full Cash Flow Statement

Margins

Gross margin is 36.46%, with operating and profit margins of -6.57% and -21.82%.

Gross Margin	36.46%
Operating Margin	-6.57%
Pretax Margin	-32.42%
Profit Margin	-21.82%
EBITDA Margin	-3.43%
EBIT Margin	-6.57%
FCF Margin	-4.21%

Dividends & Yields

Diagnostic Medical Systems does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.88%
Shareholder Yield	-15.88%
Earnings Yield	-76.50%
FCF Yield	-14.44%

Stock Splits

The last stock split was on July 21, 2016. It was a reverse split with a ratio of 0.1.

Last Split Date	Jul 21, 2016
Split Type	Reverse
Split Ratio	0.1

Scores

Diagnostic Medical Systems has an Altman Z-Score of 1.17. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.17
Piotroski F-Score	n/a